These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 27048490
1. N,N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice. Fang J, Hu F, Ke D, Yan Y, Liao Z, Yuan X, Wu L, Jiang Q, Chen L. Basic Res Cardiol; 2016 May; 111(3):32. PubMed ID: 27048490 [Abstract] [Full Text] [Related]
2. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury. Ke D, Fang J, Fan L, Chen Z, Chen L. Coron Artery Dis; 2013 Jun; 24(4):334-41. PubMed ID: 23531479 [Abstract] [Full Text] [Related]
3. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, Kao RL, Williams DL, Gao X, Li C. Cardiovasc Res; 2010 Sep 01; 87(4):694-703. PubMed ID: 20421349 [Abstract] [Full Text] [Related]
4. Targeted deletion of regulatory T cells attenuates the protective effects of myocardial ischemic preconditioning in rats. Ke D, Fang J, Fan L, Chen L. Scand Cardiovasc J; 2015 Feb 01; 49(1):64-71. PubMed ID: 25580940 [Abstract] [Full Text] [Related]
5. Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism. Jin ZQ, Karliner JS. Cardiovasc Res; 2006 Sep 01; 71(4):725-34. PubMed ID: 16831409 [Abstract] [Full Text] [Related]
6. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. Tang L, Mo Y, Li Y, Zhong Y, He S, Zhang Y, Tang Y, Fu S, Wang X, Chen A. Biochem Biophys Res Commun; 2017 May 06; 486(3):774-780. PubMed ID: 28343995 [Abstract] [Full Text] [Related]
7. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Sun Z, Tong G, Ma N, Li J, Li X, Li S, Zhou J, Xiong L, Cao F, Yao L, Wang H, Shen L. Basic Res Cardiol; 2013 May 06; 108(3):341. PubMed ID: 23463182 [Abstract] [Full Text] [Related]
8. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S. Cardiovasc Drugs Ther; 2012 Jun 06; 26(3):227-37. PubMed ID: 22392184 [Abstract] [Full Text] [Related]
12. Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3'-kinase - Akt pathway. Zhang JY, Chen ZW, Yao H. Can J Physiol Pharmacol; 2012 May 06; 90(5):637-45. PubMed ID: 22537485 [Abstract] [Full Text] [Related]
16. Activation of transient receptor potential vanilloid 1 protects the heart against apoptosis in ischemia/reperfusion injury through upregulating the PI3K/Akt signaling pathway. Jiang XX, Liu GY, Lei H, Li ZL, Feng QP, Huang W. Int J Mol Med; 2018 Mar 06; 41(3):1724-1730. PubMed ID: 29286076 [Abstract] [Full Text] [Related]
17. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo. Jin YC, Lee YS, Kim YM, Seo HG, Lee JH, Kim HJ, Yun-Choi HS, Chang KC. J Pharmacol Exp Ther; 2009 Aug 06; 330(2):440-8. PubMed ID: 19458286 [Abstract] [Full Text] [Related]